ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Equity
Sectoral
Very High Risk
+27.92%
3Y annualised
-0.81% 1D
1M
6M
1Y
3Y
5Y
All
NAV: 09 Jan '26
₹42.65
Min. SIP amount
₹100
Fund size
₹6,455.55 Cr
Expense ratio
1.02%

Return calculator

Monthly SIP
One time
Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
1 year₹60,000₹59,837
-0.27%
3 years₹1,80,000₹2,61,106
+45.06%
5 years₹3,00,000₹5,20,388
+73.46%

Holdings (39)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity12.05%
Cipla Ltd.HealthcareEquity7.90%
Dr. Reddy's Laboratories Ltd.HealthcareEquity7.82%
Divi's Laboratories Ltd.HealthcareEquity7.10%
Mankind Pharma Ltd.HealthcareEquity6.44%
Lupin Ltd.HealthcareEquity5.78%
Aurobindo Pharma Ltd.HealthcareEquity5.19%
Alkem Laboratories Ltd.HealthcareEquity3.66%
Cohance Lifesciences Ltd.HealthcareEquity3.01%
Syngene International Ltd.HealthcareEquity2.98%
Zydus Lifesciences Ltd.HealthcareEquity2.49%
Alivus Life Sciences LtdHealthcareEquity2.24%
Thyrocare Technologies Ltd.HealthcareEquity1.94%
Alembic Pharmaceuticals Ltd.HealthcareEquity1.89%
Akums Drugs And Pharmaceuticals Ltd.HealthcareEquity1.71%
Medi Assist Healthcare Services Ltd.ServicesEquity1.71%
JB Chemicals & Pharmaceuticals Ltd.HealthcareEquity1.63%
Gland Pharma Ltd.HealthcareEquity1.53%
Entero Healthcare Solutions Ltd.HealthcareEquity1.53%
Pfizer Ltd.HealthcareEquity1.40%
Medplus Health Services Ltd.HealthcareEquity1.34%
Blue Jet Healthcare Ltd.HealthcareEquity1.32%
Metropolis Healthcare Ltd.HealthcareEquity1.31%
Glenmark Pharmaceuticals Ltd.HealthcareEquity1.19%
Hikal Ltd.HealthcareEquity1.13%
Aarti Drugs Ltd.HealthcareEquity1.10%
Fine Organic Industries Ltd.ChemicalsEquity1.09%
Anthem Biosciences Ltd.HealthcareEquity1.06%
Windlas Biotech Ltd.HealthcareEquity1.06%
Shilpa Medicare Ltd.HealthcareEquity0.96%
Sanofi Consumer Healthcare India Ltd.HealthcareEquity0.86%
Laxmi Dental Ltd.HealthcareEquity0.84%
Senores Pharmaceuticals Ltd.HealthcareEquity0.82%
FDC Ltd.HealthcareEquity0.78%
Astrazeneca Pharma India Ltd.HealthcareEquity0.77%
Rubicon Research Ltd.HealthcareEquity0.76%
Procter & Gamble Health Ltd.HealthcareEquity0.63%
Sun Pharma Advanced Research Company Ltd.HealthcareEquity0.44%
Nephrocare Health Services Ltd.HealthcareEquity0.39%
See All

Minimum investments

Min. for 1st investment
₹5,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100

Returns and rankings

Annualised returns
Absolute returns
Name1Y3Y5YAll
Fund returns+0.8%+27.9%+17.8%+21.3%
Category average (Equity Sectoral)-2.1%+22.1%+14.6%--
Rank (Equity Sectoral)311--

Exit load, stamp duty and tax

Exit load

Exit load of 1% if redeemed within 15 days.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Check past data

Fund management

DK
Dharmesh Kakkad
May 2020 - Present
View details

SD
Sharmila D'Silva
Jul 2022 - Present
View details

Education
Ms. D'Silva is CA and BAF
Experience
She joined ICICI Prudential AMC Limited in September 2016.
Also manages these schemes

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 12 Oct 1993. Dharmesh Kakkad is the Current Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹10,89,373 Cr and the Latest NAV as of 09 Jan 2026 is ₹42.65. The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹5,000. Exit load of 1% if redeemed within 15 days. ;

Investment Objective

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)#3 in India
Total AUM₹10,89,372.83 Cr
Date of Incorporation12 Oct 1993
PhoneNA
E-mailNA
Launch Date12 Oct 1993
AddressOne BKC , A Wing ,13th Floor, Bandra Kurla Complex, Mumbai 400051
CustodianNA
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,